课题基金 / 基金详情

Molecular mechanisms reprogramming transcription in quiescent cells

Molecular mechanisms reprogramming transcription in quiescent cells
静止细胞中转录重编程的分子机制
批准号:
10895178
负责人:
Benjamin Roche
金额:
$18.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-01 至 2024-06-30

项目摘要

项目成果

Benjamin Roche的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long-term goal of the proposed research is to characterize the molecular mechanism(s) by which cells are reprogrammed into quiescence. This reprogramming is essential for cells to maintain viability over long periods of time without divisions, such as quiescent stem cells and memory lymphocytes. On the other hand, this reprogramming also allows early-disseminated cancer cells to evade treatment by maintaining their state of quiescence. Therefore, deciphering the mechanisms and factors involved in cellular quiescence is both a fundamental biological question and informative in health and disease. We are approaching this in a systematic manner by focusing on a model organism, the fission yeast S. pombe. This model has a ‘minimal set’ of genes allowing viable long-term quiescence, and retained epigenetic mechanisms such as histone marks and RNA interference, which are essential in non-dividing cells. By identifying this minimal set and using high-throughput approaches available in fission yeast, our goal is to understand the basic principles and key components of reprogramming in quiescence, without the confounding effects due to the added complexity of multicellular organisms, where differentiation and intercellular communication occur and affect quiescence. Among several pathways that we have found to be essential for quiescence maintenance, we are focusing specifically on two complementary factors, which are not only conserved across eukaryotes, but also most likely to impact our understanding of reprogramming: in aim 1, we will study how a core component of the Mediator complex is essential specifically in quiescent cells to maintain basal transcriptional activity; in aim 2, we will focus on ERH, a small enigmatic protein, which acts as a repressor of transcription in quiescence. We will employ a combination of genetic, genomic, biochemistry and bioinformatics approaches to understand how these two complementary regulators shape gene expression in quiescent cells. Because both Mediator and ERH are mis-expressed in cancers with strong metastatic potential, we expect our results to shed some light not only on transcriptional reprogramming in physiological quiescent cells, but also on how this process is mis-regulated in tumor dormancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms reprogramming transcription in quiescent cells
  • 批准号:
    10895617
  • 项目类别:
  • 资助金额:
    $18.86万
  • 财政年份:
    2023
  • 负责人:
    Benjamin Roche
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: